CIK: 0001263508 · Show all filings
Period: Q4 2014 (← Previous) (Next →)
Filing Date: Feb 17, 2015
Total Value ($000): $9,797,208 (79.0% shares, 21.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Pharmacyclics Inc. | 9,129,231 | $1,116,140 | 11.4% | $80.38 | — | COM | 716933106 |
| INCY | Incyte Corp. | 14,845,559 | $1,085,359 | 11.1% | $21.85 | +199.0% | COM | 45337C102 |
| — | Synageva Biopharma Corp. | 10,660,432 | $989,182 | 10.1% | $45.53 | — | COM | 87159A103 |
| — | Seattle Genetics, Inc. | 27,861,720 | $895,197 | 9.1% | $32.44 | — | COM | 812578102 |
| — | Avanir Pharmaceuticals | 38,513,713 | $652,807 | 6.7% | $10.98 | — | COM | 05348P401 |
| ACAD | Acadia Pharmaceuticals Inc. | 20,481,442 | $650,286 | 6.6% | $14.07 | +101.5% | COM | 004225108 |
| — | Salix 2.75% 5/15/15 | 219,440,000 | $542,741 | 5.5% | $1.52 | — | CONV BONDS | 795435AC0 |
| — | Genomic Health Inc. | 13,656,318 | $436,592 | 4.5% | $31.71 | — | COM | 37244C101 |
| — | Incyte Corporation Notes 1.25% 11/15/2020 144A | 274,500,000 | $421,613 | 4.3% | $1.21 | — | CONV BONDS | 45337CAL6 |
| — | Incyte Corporation Notes 0.375% 11/15/2018 144A | 259,000,000 | $388,039 | 4.0% | $1.20 | — | CONV BONDS | 45337CAK8 |
| — | Incyte Corporation Notes 4.75% 10/1/2015 144A | 40,446,000 | $336,182 | 3.4% | $6.08 | — | CONV BONDS | 45337CAJ1 |
| BMRN | Biomarin Pharmaceuticals | 3,713,950 | $335,741 | 3.4% | $71.95 | +15.6% | COM | 09061G101 |
| — | Anacor Pharmaceuticals | 4,204,702 | $135,602 | 1.4% | $19.02 | — | COM | 032420101 |
| BCRX | Biocryst Pharmaceuticals Inc. | 10,713,686 | $130,278 | 1.3% | $5.72 | +93.0% | COM | 09058V103 |
| — | Biomarin Pharmaceuticals Notes 1.875% 4/23/2017 | 22,898,000 | $102,104 | 1.0% | $2.76 | — | CONV BONDS | 09061GAD3 |
| — | Bellicum Pharmaceuticals, Inc. | 4,283,732 | $98,697 | 1.0% | $23.04 | — | COM | 079481107 |
| — | Gilead 1.625% 5/1/16 | 21,500,000 | $88,977 | 0.9% | $2.26 | — | CONV BONDS | 375558AP8 |
| — | Dyax Corp. | 6,157,789 | $86,579 | 0.9% | $8.91 | — | COM | 26746E103 |
| CERS | Cerus | 11,702,727 | $73,025 | 0.7% | $4.62 | -1.7% | COM | 157085101 |
| — | Salix Pharmaceuticals | 635,321 | $73,024 | 0.7% | $114.73 | — | COM | 795435106 |
| — | Acorda Therapeutics Notes 1.75% 6/15/2021 | 60,900,000 | $69,839 | 0.7% | $1.04 | — | CONV BONDS | 00484MAA4 |
| — | Medivation 2.625% 4/1/17 | 34,720,000 | $67,334 | 0.7% | $1.27 | — | CONV BONDS | 58501NAA9 |
| VNDA | Vanda Pharmaceuticals, Inc. | 4,472,153 | $64,041 | 0.7% | $7.51 | +57.5% | COM | 921659108 |
| — | Xoma Corp. | 16,924,013 | $60,757 | 0.6% | $3.73 | — | COM | 98419J107 |
| — | Xenoport | 6,903,628 | $60,545 | 0.6% | $5.27 | — | COM | 98411C100 |
| — | Versartis Inc. | 2,281,744 | $51,225 | 0.5% | $25.50 | — | COM | 92529L102 |
| — | Mirati Therapeutics Inc. | 2,380,074 | $44,079 | 0.4% | $15.40 | — | COM | 60468T105 |
| — | DBV Technologies Inc. | 1,519,229 | $41,201 | 0.4% | $27.12 | — | SPONSORED ADR | 23306J101 |
| — | Progenics Pharmaceuticals, Inc. | 4,449,797 | $33,640 | 0.3% | $4.44 | — | COM | 743187106 |
| — | Derma Sciences | 3,537,137 | $32,931 | 0.3% | $12.84 | — | COM | 249827502 |
| TGTX | TG Therapeutics | 2,050,313 | $32,477 | 0.3% | $4.61 | +182.7% | COM | 88322Q108 |
| — | Acorda Therapeutics, Inc. | 755,534 | $30,879 | 0.3% | $37.91 | — | COM | 00484M106 |
| — | Salix 1.5% 3/15/19 | 15,000,000 | $27,339 | 0.3% | $1.49 | — | CONV BONDS | 795435AE6 |
| HALO | Halozyme Therapeutics Inc. | 2,776,143 | $26,790 | 0.3% | $6.50 | +36.7% | COM | 40637H109 |
| HRTX | Heron Therapeutics, Inc. | 2,607,784 | $26,234 | 0.3% | $12.49 | -34.7% | COM | 427746102 |
| GILD | Gilead Sciences Inc. | 256,108 | $24,141 | 0.2% | $36.21 | +98.4% | COM | 375558103 |
| CPRX | Catalyst Pharmaceuticals, Inc. | 6,715,462 | $19,945 | 0.2% | $2.45 | +11.9% | COM | 14888U101 |
| — | Repros Therapeutics | 2,000,000 | $19,940 | 0.2% | $18.45 | — | COM | 76028H209 |
| AGIO | Agios Pharmaceuticals | 163,393 | $18,307 | 0.2% | $27.47 | +225.0% | COM | 00847X104 |
| INSM | Insmed Inc. | 1,107,850 | $17,138 | 0.2% | $13.86 | +2.4% | COM | 457669307 |
| OMER | Omeros Corp. | 648,101 | $16,060 | 0.2% | $7.65 | +138.3% | COM | 682143102 |
| — | Biomarin Pharmaceuticals Notes 0.75% 10/15/2018 | 12,500,000 | $14,715 | 0.2% | $1.06 | — | CONV BONDS | 09061GAE1 |
| SGMO | Sangamo Biosciences, Inc. | 955,332 | $14,531 | 0.1% | $12.63 | -3.9% | COM | 800677106 |
| — | Bluebird Bio Inc. | 150,000 | $13,758 | 0.1% | $25.09 | — | COM | 09609G100 |
| NBIX | Neurocrine Biosciences, Inc. | 554,590 | $12,390 | 0.1% | $16.53 | +14.6% | COM | 64125C109 |
| — | Clovis Oncology | 202,630 | $11,347 | 0.1% | $56.00 | — | COM | 189464100 |
| MGNX | Macrogenics, Inc. | 311,891 | $10,938 | 0.1% | $22.61 | +10.3% | COM | 556099109 |
| — | Kythera Biopharmaceuticals | 286,255 | $9,927 | 0.1% | $34.55 | — | COM | 501570105 |
| XNCR | Xencor | 591,371 | $9,486 | 0.1% | $8.83 | +31.4% | COM | 98401F105 |
| — | Arrowhead Research Corp. | 1,230,802 | $9,083 | 0.1% | $9.90 | — | COM | 042797209 |
| — | Aquinox Pharmaceuticals, Inc. | 1,210,350 | $9,078 | 0.1% | $12.73 | — | COM | 03842B101 |
| — | Aerie Pharmaceuticals | 299,356 | $8,738 | 0.1% | $17.96 | — | COM | 00771V108 |
| PRQR | ProQR Therapeutics NV | 400,000 | $8,668 | 0.1% | $16.02 | -5.3% | SHS | N71542109 |
| — | Osiris Therapeutics Inc. | 510,606 | $8,165 | 0.1% | $16.34 | — | COM | 68827R108 |
| — | Sunesis Pharmaceuticals Inc. | 3,200,000 | $8,160 | 0.1% | $2.55 | — | COM | 867328601 |
| — | La Jolla Pharmaceuticals, Inc. | 421,631 | $7,779 | 0.1% | $10.24 | — | COM | 503459604 |
| — | Tekmira Pharmaceuticals Corp. | 484,156 | $7,335 | 0.1% | $7.97 | — | COM | 87911B209 |
| — | Celladon Corp | 375,000 | $7,324 | 0.1% | $10.46 | — | COM | 15117E107 |
| — | Novavax Inc. | 1,223,362 | $7,255 | 0.1% | $3.15 | — | COM | 670002104 |
| — | Idera Pharmaceuticals Inc. | 1,628,172 | $7,181 | 0.1% | $0.91 | — | COM | 45168K306 |
| — | Foamix Pharmaceuticals Ltd. | 1,021,600 | $7,161 | 0.1% | $5.45 | — | SHS | M46135105 |
| — | Chimerix | 172,414 | $6,941 | 0.1% | $40.26 | — | COM | 16934W106 |
| — | Threshold Pharma | 2,155,516 | $6,855 | 0.1% | $4.49 | — | COM | 885807206 |
| — | Array Biopharma Inc. | 1,433,797 | $6,782 | 0.1% | $4.54 | — | COM | 04269X105 |
| — | Concert Pharmaceuticals, Inc. | 505,418 | $6,732 | 0.1% | $10.71 | — | COM | 206022105 |
| RARE | Ultragenyx Pharmaceuticals | 150,000 | $6,582 | 0.1% | $51.09 | -10.3% | COM | 90400D108 |
| — | QLT Inc. | 1,535,863 | $6,159 | 0.1% | $4.39 | — | COM | 746927102 |
| — | Isis Pharmaceuticals, Inc. | 96,303 | $5,946 | 0.1% | $26.87 | — | COM | 464330109 |
| — | Stemline Therapeutics Inc. | 338,671 | $5,778 | 0.1% | $23.84 | — | COM | 85858C107 |
| — | Achillion | 438,337 | $5,370 | 0.1% | $8.18 | — | COM | 00448Q201 |
| IRWD | Ironwood Pharmaceuticals | 346,160 | $5,303 | 0.1% | $11.63 | -1.6% | COM | 46333X108 |
| INFIQ | Infinity Pharmaceuticals Inc. | 312,025 | $5,270 | 0.1% | $13.42 | +8.5% | COM | 45665G303 |
| — | Juno Therapeutics Inc. | 100,000 | $5,222 | 0.1% | $52.22 | — | COM | 48205A109 |
| — | Mallinckrodt PUB LTD CO | 46,666 | $4,621 | 0.0% | $90.15 | — | SHS | G5785G107 |
| — | Alder Biopharmaceutical Inc. | 153,350 | $4,461 | 0.0% | $20.07 | — | COM | 014339105 |
| — | Discovery Laboratories Inc. | 3,652,117 | $4,236 | 0.0% | $1.95 | — | COM | 254668403 |
| FOLD | Amicus Therapeutics | 481,697 | $4,008 | 0.0% | $3.07 | +123.3% | COM | 03152W109 |
| — | Ignyta | 571,000 | $3,911 | 0.0% | $8.30 | — | COM | 451731103 |
| LGND | Ligand Pharmaceuticals | 73,400 | $3,906 | 0.0% | $41.68 | -22.0% | COM | 53220K504 |
| ENTA | Enanta Pharmaceuticals | 75,357 | $3,832 | 0.0% | $19.50 | +129.6% | COM | 29251M106 |
| — | Epizyme Inc. | 201,963 | $3,811 | 0.0% | $21.47 | — | COM | 29428V104 |
| — | Cytrx Corp. | 1,350,000 | $3,699 | 0.0% | $3.49 | — | COM | 232828509 |
| — | Karyopharm Therapeutics | 94,095 | $3,522 | 0.0% | $31.71 | — | COM | 48576U106 |
| — | Neuroderm Ltd. | 250,000 | $3,510 | 0.0% | $14.04 | — | ORD SHS | M74231107 |
| — | Celsus Therapeutics | 673,887 | $3,235 | 0.0% | $6.49 | — | SPONSORED ADR NE | 15119A202 |
| — | Zogenix, Inc. | 2,350,400 | $3,220 | 0.0% | $2.18 | — | COM | 98978L105 |
| — | Synergy Pharmaceuticals | 973,245 | $2,968 | 0.0% | $4.32 | — | COM | 871639308 |
| — | Receptos Inc. | 23,900 | $2,928 | 0.0% | $19.89 | — | COM | 756207106 |
| — | Aptose Biosciences, Inc. | 479,164 | $2,833 | 0.0% | $5.91 | — | COM | 03835T200 |
| — | Foundation Medicine Inc. | 126,147 | $2,803 | 0.0% | $25.16 | — | COM | 350465100 |
| — | Sage Therapeutics Inc. | 75,000 | $2,745 | 0.0% | $31.51 | — | COM | 78667J108 |
| — | Mast Therapeutics, Inc. | 4,774,434 | $2,674 | 0.0% | $0.56 | — | COM | 576314108 |
| — | Protalix Biotherapeutics, Inc. Notes 4.5% 9/15/18 | 3,500,000 | $2,645 | 0.0% | $0.76 | — | CONV BONDS | 74365AAB7 |
| — | Lipocine Inc. | 500,000 | $2,630 | 0.0% | $6.10 | — | COM | 53630X104 |
| AUPH | Aurinia Pharmaceuticals, Inc. | 727,669 | $2,599 | 0.0% | $3.55 | -0.9% | COM | 05156V102 |
| — | BioDelivery Sciences Intl. Inc. | 210,021 | $2,524 | 0.0% | $4.06 | — | COM | 09060J106 |
| — | Affimed Therapeutics B.V. | 400,000 | $2,480 | 0.0% | $6.30 | — | COM | N01045108 |
| — | Biota Pharmaceuticals | 1,106,910 | $2,479 | 0.0% | $4.19 | — | COM | 090694100 |
| OSUR | Orasure Technologies Inc. | 234,664 | $2,379 | 0.0% | $4.46 | +100.9% | COM | 68554V108 |
| — | Marinus Pharmaceuticals Inc. | 204,476 | $2,161 | 0.0% | $6.47 | — | COM | 56854Q101 |
| — | Dermira | 100,000 | $1,811 | 0.0% | $18.11 | — | COM | 24983L104 |
| — | Proteon Therapeutics, Inc. | 172,917 | $1,798 | 0.0% | $10.40 | — | COM | 74371L109 |
| — | Ophthotech Corp. | 36,776 | $1,650 | 0.0% | $32.35 | — | COM | 683745103 |
| — | Mediwound Ltd. | 225,000 | $1,499 | 0.0% | $11.38 | — | ORD SHS | M68830104 |
| — | Palatin Technologies Inc. | 2,050,000 | $1,497 | 0.0% | $0.73 | — | COM | 696077403 |
| — | Synta Pharmaceuticals | 500,000 | $1,325 | 0.0% | $4.99 | — | COM | 87162T206 |
| GERN | Geron Corp. | 402,629 | $1,309 | 0.0% | $1.08 | +155.1% | COM | 374163103 |
| — | Achaogen Inc. | 100,000 | $1,305 | 0.0% | $15.46 | — | COM | 004449104 |
| — | Loxo Oncology Inc. | 100,000 | $1,175 | 0.0% | $13.13 | — | COM | 548862101 |
| — | Tesaro Inc. | 31,218 | $1,161 | 0.0% | $32.74 | — | COM | 881569107 |
| ALNY | Alnylam Pharmaceuticals, Inc. | 11,600 | $1,125 | 0.0% | $77.42 | +19.7% | COM | 02043Q107 |
| — | Acceleron Pharma Inc. | 28,765 | $1,121 | 0.0% | $39.60 | — | COM | 00434H108 |
| — | Rigel Pharmaceuticals | 481,972 | $1,094 | 0.0% | $3.58 | — | COM | 766559603 |
| — | Alcobra Ltd. | 289,871 | $1,081 | 0.0% | $3.73 | — | SHS | M2239P109 |
| — | Ziopharm Oncology Inc. | 193,640 | $982 | 0.0% | $2.11 | — | COM | 98973P101 |
| — | Five Prime Therapeutics Inc. | 19,823 | $535 | 0.0% | $16.80 | — | COM | 33830X104 |
| QURE | UniQure B.V. | 30,672 | $454 | 0.0% | $15.95 | -23.3% | SHS | N90064101 |
| — | Chemocentryx Inc. | 50,000 | $342 | 0.0% | $14.14 | — | COM | 16383L106 |
| — | Cyclacel Pharmaceuticals Pfd. Conv. Ex 6% | 13,253 | $82 | 0.0% | $7.20 | — | PFD CONV EX 6% | 23254L207 |
| — | Asterias Biotherapeutics, Inc. | 16,775 | $54 | 0.0% | $3.22 | — | COM SER A | 04624N107 |
| — | Biotime Inc. Rights | 20,525 | $22 | 0.0% | $1.07 | — | COM | 09066L162 |